Sarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people

被引:0
作者
S. Molino
M. Dossena
D. Buonocore
Manuela Verri
机构
[1] Università degli Studi di Pavia,Dipartimento di Biologia e Biotecnologie “Lazzaro Spallanzani”
来源
The journal of nutrition, health & aging | 2016年 / 20卷
关键词
Sarcopenic obesity; body composition; aging; cardio-metabolic risk; exercise; amino acids;
D O I
暂无
中图分类号
学科分类号
摘要
Today’s increased life expectancy highlights both age-related changes in body composition and a higher prevalence of obesity. Sarcopenic obesity (SO) is assuming a prominent role in cardio-metabolic risk because of the double metabolic burden derived from low muscle mass (sarcopenia) and excess adiposity (obesity). This review evaluates the related studies that have been published over the past 10 years in order to give an updated overview of this new syndrome. There is no consensus on the definition of SO due to the wide heterogeneity of diagnostic criteria and choice of body composition components needed to assess this phenotype. There is a growing body of evidence that the ethio-pathogenesis of SO is complex and multi-factorial, as the consequences are a combination of the outcomes of both sarcopenia and obesity, where the effects are maximised. In order to manage SO, it is important to make lifestyle changes that incorporate weight loss, physical exercise and protein supplementation.
引用
收藏
页码:780 / 788
页数:8
相关论文
共 504 条
  • [1] Visser M(2005)Muscle Mass, Muscle Strength, and Muscle Fat Infiltration as Predictors of Incident Mobility Limitations in Well-Functioning Older Persons J Gerontol A Biol Sci Med Sci 60 324-333
  • [2] Goodpaster BH(2009)Longitudinal study of muscle strength, quality, and adipose tissue infiltration Am J Clin Nutr 90 1579-1585
  • [3] Kritchevsky SB(2014)Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity Endocrine 47 699-716
  • [4] Newman AB(2007)Fat Mass But Not Fat-Free Mass Is Related to Physical Capacity in Well-Functioning Older Individuals: Nutrition as a Determinant of Successful Aging (NuAge)—The Quebec Longitudinal Study J Gerontol A Biol Sci Med Sci 62 1382-1388
  • [5] Nevitt M(1997)Symposium: Sarcopenia: Diagnosis and Mechanisms Sarcopenia: Origins and Clinical Relevance J Nutr 127 990-991
  • [6] Rubin SM(2007)Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia Clin Nutr 26 389-99
  • [7] Simonsick EM(2013)The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size Exp Gerontol 48 492-498
  • [8] Harris TB(2011)Sarcopenia: An Undiagnosed Condition in Older Adults Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 12 249-256
  • [9] Delmonico MJ(2009)Epidemiology and consequences of sarcopenia J Nutr Health Aging 13 708-12
  • [10] Harris TB(2006)The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study J Gerontol A Biol Sci Med Sci 61 1059-1064